352 related articles for article (PubMed ID: 26084672)
1. Perturbation of the normal immune system in patients with CLL.
Forconi F; Moss P
Blood; 2015 Jul; 126(5):573-81. PubMed ID: 26084672
[TBL] [Abstract][Full Text] [Related]
2. Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Haseeb M; Anwar MA; Choi S
Front Immunol; 2018; 9():2720. PubMed ID: 30542344
[TBL] [Abstract][Full Text] [Related]
3. Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape.
Sampalo A; Brieva JA
Leuk Lymphoma; 2002 Apr; 43(4):881-4. PubMed ID: 12153179
[TBL] [Abstract][Full Text] [Related]
4. B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber D; Qi Y; Maeding N; Steiner M; Denk U; Höpner JP; Hartmann TN; Zaborsky N; Greil R; Egle A
Blood; 2019 Nov; 134(20):1717-1729. PubMed ID: 31537531
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
6. Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.
Arruga F; Gyau BB; Iannello A; Vitale N; Vaisitti T; Deaglio S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155826
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of T cell/B cell interaction by B-CLL cells.
Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
[TBL] [Abstract][Full Text] [Related]
8. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R; Gribben J
Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
[TBL] [Abstract][Full Text] [Related]
9. The immunodeficiency of chronic lymphocytic leukaemia.
Hamblin AD; Hamblin TJ
Br Med Bull; 2008; 87():49-62. PubMed ID: 18755702
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
11. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
14. Infection and immunity in chronic lymphocytic leukemia.
Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
[TBL] [Abstract][Full Text] [Related]
15. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
Hanna BS; Öztürk S; Seiffert M
Mol Immunol; 2019 Jun; 110():77-87. PubMed ID: 29173971
[TBL] [Abstract][Full Text] [Related]
16. Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes.
Tomita Y; Avila-Cariño J; Yamamoto K; Mellstedt H; Klein E
Immunol Lett; 1998 Feb; 60(2-3):73-9. PubMed ID: 9580478
[TBL] [Abstract][Full Text] [Related]
17. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia].
Stelmach P; Robak T
Postepy Hig Med Dosw (Online); 2013 Jun; 67():560-8. PubMed ID: 23799400
[TBL] [Abstract][Full Text] [Related]
19. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.
Sun C; Tian X; Lee YS; Gunti S; Lipsky A; Herman SE; Salem D; Stetler-Stevenson M; Yuan C; Kardava L; Moir S; Maric I; Valdez J; Soto S; Marti GE; Farooqui MZ; Notkins AL; Wiestner A; Aue G
Blood; 2015 Nov; 126(19):2213-9. PubMed ID: 26337493
[TBL] [Abstract][Full Text] [Related]
20. Selection and expansion of T cell from untreated patients with CLL: source of cells for immune reconstitution?
Husebekk A; Fellowes V; Read EJ; Williams J; Petrus MJ; Gress RE; Fowler DH
Cytotherapy; 2000; 2(3):187-93. PubMed ID: 12042041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
